Lindsay Clancy’s husband could testify for her at trial over deaths of their three children

Trial begins for Lindsay Clancy, charged with murdering her three children Plymouth Superior Court in Duxbury, Massachusetts, has opened its doors to the trial of Lindsay Clancy, a 35-year-old woman accused of killing her three children, Cora, 5; Dawson, 3; and Callan, 8 months old, in January 2023. The courtroom will host jury selection starting Monday, February 20, 2026, marking the start of a legal battle centered around postpartum mental health and alleged medical failures. The case has drawn national attention due to the tragic nature of the crime and the complex psychological factors surrounding it. According to court filings, Clancy, a former nurse working in labor and delivery at Massachusetts General Hospital, is seeking an insanity defense, arguing that her actions were the result of untreated postpartum psychosis. The prosecution, however, contends that Clancy had access to medical care and failed to seek help despite experiencing severe symptoms. Lindsay Clancy’s husband, Patrick, is set to testify in her defense during the trial. He has stated that the couple believes the medical professionals who treated Clancy misdiagnosed her condition and overmedicated her, leading to hallucinations that she claims instructed her to harm her children. The couple maintains that the doctors failed to recognize the severity of her mental state and instead prescribed a series of medications that allegedly exacerbated her condition. The legal proceedings include an amended complaint filed in Norfolk Superior Court, which outlines Clancy’s claim against the psychiatric providers involved in her care. The document alleges that these providers misdiagnosed her with bipolar disorder, failed to coordinate treatment effectively, and prescribed a variety of medications without considering how they might affect her mental state. The complaint further states that Clancy reported intrusive thoughts and auditory hallucinations, which she believed were warning signs of a deteriorating mental state. According to the filing, Clancy began exhibiting signs of hypomania shortly after giving birth to her youngest child, Callan, in May 2022. By approximately 12 weeks postpartum, her condition reportedly worsened significantly, with symptoms including severe anxiety, depression, exhaustion, and insomnia. She claimed she was sleeping only a few hours each night and struggled with even basic daily tasks. The lawsuit asserts that these symptoms should have prompted medical professionals to consider antidepressant-induced activation and possible bipolar disorder. Despite these concerns, the complaint suggests that Clancy was moved through multiple medications, including Zoloft, Prozac, Ambien, Remeron, Klonopin, Seroquel, Trazodone, Valium, and Amitriptyline, without adequate communication between providers. It further claims that the medical team failed to obtain a comprehensive psychiatric history and neglected to recognize that the antidepressants may have worsened her symptoms. An incident involving the police and emergency responders in late November 2022 is also referenced in the legal documents. At that time, Clancy was reportedly under the influence of Remeron and exhibited erratic behavior. Emergency dispatch records suggest that first responders were alerted to a frantic call from Clancy, indicating distress and confusion. The details of this encounter remain unclear, though it highlights the growing instability in her mental state during the period preceding the fatal incident. As the trial proceeds, the focus will likely shift toward the credibility of Clancy’s claims regarding medical misdiagnosis and the role of medication in exacerbating her condition. The testimony of Patrick Clancy and other potential witnesses will play a crucial role in shaping the narrative presented to the jury. Legal experts anticipate that the case will continue to draw public interest, given its intersection with issues of maternal mental health and the responsibilities of healthcare providers in such cases.